Boehringer Ingelheim Announces Positive Phase II Results for Once-Daily Tiotropium in Asthma Ingelheim, Germany:
For Media outside the U.S., Canada and UK
Dr Christian Vogelberg, University Children’s Hospital Dresden, Germany, Lead Author (Photo: Business Wire)
A Phase II study has presented at the 2012 Annual Meeting of the
American Thoracic Society showed positive results for once-daily
tiotropium via the Respimat Soft Mist™ Inhaler (SMI) device
Women with excess weight, both before pregnancy and gained during pregnancy, may be at risk of having larger than average babies, which can result in increased risk of cesarean section or trauma
More than a third of the malaria-fighting drugs tested over the past decade in Southeast Asia and sub-Saharan Africa were either fake or bad quality, seriously undermining efforts to fight the
1,600 museums offer military families free tickets
More than 1,600 museums across the country will offer free admission to active-duty military personnel and their families this summer in a program that has more than doubled in size since 2010.
1,600 museums offer military families free tickets
More than 1,600 museums across the country will offer free admission to active-duty military personnel and their families this summer in a program that has more than doubled in size since 2010.
